Nektar Therapeutics (LON:0UNL)

Nektar Therapeutics Statistics

Total Valuation

LON:0UNL has a market cap or net worth of GBP 859.11 million. The enterprise value is 859.73 million.

Market Cap	859.11M
Enterprise Value	859.73M

Important Dates

The next estimated earnings date is Wednesday, November 5, 2025.

Earnings Date	Nov 5, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	19.02M
Shares Outstanding	n/a
Shares Change (YoY)	+7.17%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	0.78%
Owned by Institutions (%)	40.97%
Float	17.59M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	15.71
PB Ratio	-48.62
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-9.63
EV / Sales	15.26
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.33

Financial Position

The company has a current ratio of 2.61

Current Ratio	2.61
Quick Ratio	2.48
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-0.95
Interest Coverage	-5.24

Financial Efficiency

Return on equity (ROE) is -440.80% and return on invested capital (ROIC) is -38.49%.

Return on Equity (ROE)	-440.80%
Return on Assets (ROA)	-31.57%
Return on Invested Capital (ROIC)	-38.49%
Return on Capital Employed (ROCE)	-102.19%
Revenue Per Employee	896,628
Profits Per Employee	-1.46M
Employee Count	61
Asset Turnover	0.27
Inventory Turnover	n/a

Taxes

Income Tax	-281,741
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +197.22% in the last 52 weeks. The beta is 0.58, so LON:0UNL's price volatility has been lower than the market average.

Beta (5Y)	0.58
52-Week Price Change	+197.22%
50-Day Moving Average	47.88
200-Day Moving Average	25.79
Relative Strength Index (RSI)	60.15
Average Volume (20 Days)	5,326

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.74

Income Statement

In the last 12 months, LON:0UNL had revenue of GBP 54.69 million and -89.25 million in losses. Loss per share was -6.36.

Revenue	54.69M
Gross Profit	45.63M
Operating Income	-101.55M
Pretax Income	-89.53M
Net Income	-89.25M
EBITDA	-100.12M
EBIT	-101.55M
Loss Per Share	-6.36

Balance Sheet

The company has 128.39 million in cash and 128.99 million in debt, giving a net cash position of -602,897.

Cash & Cash Equivalents	128.39M
Total Debt	128.99M
Net Cash	-602,897
Net Cash Per Share	n/a
Equity (Book Value)	-17.67M
Book Value Per Share	-1.42
Working Capital	84.07M

Cash Flow

In the last 12 months, operating cash flow was -134.97 million and capital expenditures -849,604, giving a free cash flow of -135.82 million.

Operating Cash Flow	-134.97M
Capital Expenditures	-849,604
Free Cash Flow	-135.82M
FCF Per Share	n/a

Margins

Gross margin is 83.44%, with operating and profit margins of -185.67% and -163.17%.

Gross Margin	83.44%
Operating Margin	-185.67%
Pretax Margin	-163.69%
Profit Margin	-163.17%
EBITDA Margin	-183.05%
EBIT Margin	-185.67%
FCF Margin	n/a

Dividends & Yields

LON:0UNL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.17%
Shareholder Yield	-7.17%
Earnings Yield	-10.39%
FCF Yield	-15.81%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 9, 2025. It was a reverse split with a ratio of 0.0666666667.

Last Split Date	Jun 9, 2025
Split Type	Reverse
Split Ratio	0.0666666667

Scores

LON:0UNL has an Altman Z-Score of -25.58 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-25.58
Piotroski F-Score	3